Key Takeaways
- Mesothelioma is a rare cancer, so researchers have a small pool of patients for clinical trials and often need to collaborate across medical centers and countries.
- The disease can take decades to develop after asbestos exposure, which makes prevention research and exposure reconstruction especially difficult.
- Mesothelioma is not one disease: pleural, peritoneal, pericardial, and testicular forms can behave differently and respond differently to treatment.
- Symptoms such as shortness of breath, chest pain, abdominal swelling, and fatigue resemble more common conditions, which can delay diagnosis.
- Researchers are studying immunotherapy, targeted therapies, combination treatments, biomarkers, and improved surgical and radiation techniques.
- Anyone diagnosed with mesothelioma after asbestos exposure may have legal options, and a detailed work and residential history is key to identifying the source of exposure.
Understanding why mesothelioma research is so difficult can help explain why scientists continue to study the disease and search for better ways to detect and treat it.
Mesothelioma Is a Rare Cancer
One of the most significant challenges facing mesothelioma researchers is its rarity.
Compared with more common cancers such as breast, lung, or prostate cancer, relatively few people are diagnosed with mesothelioma each year. This means researchers have a much smaller pool of patients available for clinical trials and other studies.
Large studies can help scientists identify patterns and determine whether a treatment works consistently across different groups of patients. With a rare disease, however, recruiting enough participants can take considerably longer.
Experienced. Dedicated. Proven. We fight for Mesothelioma Victims.
Find Out If You Qualify for Compensation
With over 35 years of experience, the Halpern Law Firm is ready to fight for you. Get a free, no-obligation case review today and take the first step toward the compensation you deserve.
Researchers may also need to work with medical centers across different regions or countries to gather enough patients for a study. This can make clinical research more complicated and expensive.
Mesothelioma Can Take Decades to Develop
Another challenge is the long period between asbestos exposure and the development of mesothelioma.
Mesothelioma has a long latency period. A person may have been exposed to asbestos decades before receiving a diagnosis. In some cases, the exposure occurred during employment many years earlier, making it difficult to reconstruct exactly when, where, and how the exposure happened.
This long latency period also makes prevention research challenging. Researchers cannot simply observe a group of people for a short period and determine who will eventually develop mesothelioma.
Instead, understanding the relationship between asbestos exposure and mesothelioma has required decades of epidemiological and medical research.
Mesothelioma Is Not Just One Disease
Mesothelioma can develop in different parts of the body. The most common type is pleural mesothelioma, which affects the lining surrounding the lungs. Other forms include peritoneal mesothelioma, which develops in the lining of the abdomen, and rarer forms such as pericardial and testicular mesothelioma.
These different forms can behave differently and may require different approaches to treatment.
Even among people with pleural mesothelioma, the cancer can vary from one patient to another. Differences in tumor biology, stage, overall health, and other factors can affect how someone responds to treatment.
This variability makes it difficult for researchers to identify a single treatment that works equally well for everyone.
Mesothelioma Can Be Difficult to Diagnose
Early diagnosis is another area of ongoing research.
The symptoms of mesothelioma can resemble those of more common conditions. Depending on where the cancer develops, symptoms may include shortness of breath, chest pain, abdominal swelling, abdominal pain, fatigue, or unexplained weight loss.
Because mesothelioma is uncommon, it may not immediately be considered when a patient first develops these symptoms.
Researchers continue to investigate ways to identify mesothelioma earlier, including potential biomarkers and improved imaging and diagnostic techniques. Earlier detection could give doctors more opportunities to consider available treatment options.
Researchers Need Enough Clinical Trial Participants
Clinical trials are an important part of developing new cancer treatments. However, enrolling enough people with a rare cancer can be difficult.
Patients may live far from specialized cancer centers conducting trials. Eligibility requirements may also limit who can participate. In addition, some patients may have already undergone several treatments by the time they qualify for a particular study.
Researchers must also account for differences between patients when evaluating a treatment. Age, cancer stage, tumor characteristics, previous treatments, and overall health can all affect study results.
These factors can make it harder to determine whether a treatment is responsible for an outcome or whether other differences between patients played a role.
Asbestos Exposure Can Be Difficult to Reconstruct
Mesothelioma research also depends heavily on understanding asbestos exposure.
Asbestos was widely used in construction, manufacturing, shipbuilding, automotive work, power plants, industrial facilities, and many other settings for decades. Workers could encounter asbestos in insulation, cement products, machinery components, building materials, and other products.
Some people were exposed through their jobs, while others may have encountered asbestos through home renovations or by coming into contact with asbestos fibers brought home on a worker’s clothing.
Because mesothelioma can develop decades after exposure, identifying the source of exposure may require looking far back into a person’s employment and residential history.
Researchers Are Studying New Approaches
Despite these challenges, mesothelioma research continues to advance.
Researchers are studying a variety of approaches, including immunotherapy, targeted therapies, combination treatments, biomarkers, and improved surgical and radiation techniques. Scientists are also working to better understand the genetic and molecular characteristics of mesothelioma.
Clinical trials remain an important part of this process. Because mesothelioma is relatively rare, collaboration between researchers and medical centers can be particularly important in developing new knowledge about the disease.
Every study contributes to a larger understanding of how mesothelioma develops, how it behaves, and how it may be treated.
The Importance of Continued Mesothelioma Research
Mesothelioma research presents challenges that researchers do not encounter to the same degree with more common cancers. Its rarity, long latency period, different disease types, complex tumor biology, and difficulty recruiting clinical trial participants can all make research more difficult.
Still, decades of research have helped doctors and scientists better understand the connection between asbestos exposure and mesothelioma and have contributed to the development of additional diagnostic and treatment options.
Continued research is important for patients and families affected by this disease. As scientists learn more about mesothelioma, they can continue searching for ways to detect the cancer earlier, improve treatment, and ultimately improve outcomes for people diagnosed with this asbestos-related disease.
If you or a loved one has been diagnosed with mesothelioma after asbestos exposure, learning about the disease and understanding your legal options can be important.
For more information or to speak to one of our mesothelioma attorneys, call (800) 505-6000, fill out our contact form, or utilize our chat feature. The Halpern Law Firm represents individuals and families affected by asbestos exposure and mesothelioma throughout Pennsylvania.
Frequently Asked Questions
Why is mesothelioma so hard to research?
Mesothelioma is rare, takes decades to develop after asbestos exposure, and appears in several different forms with varying tumor biology. Together, these factors make it difficult to recruit enough patients for studies and to identify a single treatment that works consistently for everyone.
How rare is mesothelioma?
Mesothelioma is far less common than breast, lung, or prostate cancer. Roughly 3,000 people are diagnosed in the United States each year, which gives researchers a much smaller pool of patients for clinical trials.
How long does it take mesothelioma to develop after asbestos exposure?
Mesothelioma has a long latency period, often 20 to 50 years between asbestos exposure and diagnosis. Many patients were exposed at work decades earlier, which can make it difficult to reconstruct exactly when, where, and how the exposure happened.
What are the different types of mesothelioma?
The most common type is pleural mesothelioma, which affects the lining around the lungs. Peritoneal mesothelioma develops in the lining of the abdomen. Pericardial mesothelioma, affecting the lining of the heart, and testicular mesothelioma are much rarer. Each form can behave differently and may require a different treatment approach.
Why is mesothelioma often diagnosed late?
Symptoms such as shortness of breath, chest pain, abdominal swelling, abdominal pain, fatigue, and unexplained weight loss can resemble more common conditions. Because mesothelioma is uncommon, doctors may not consider it right away, especially if they don’t know about a patient’s asbestos exposure history.
What new mesothelioma treatments are being studied?
Researchers are studying immunotherapy, targeted therapies, combination treatments, biomarkers for earlier detection, and improved surgical and radiation techniques. Scientists are also working to better understand the genetic and molecular characteristics of mesothelioma tumors.
Can I join a clinical trial and still pursue a legal claim?
Yes. Participating in a clinical trial does not prevent you from pursuing compensation for asbestos exposure. Compensation from a claim can also help cover treatment costs, travel to specialized cancer centers, and other expenses related to your care.
Why does my asbestos exposure history matter?
Your work and residential history helps doctors understand your diagnosis and helps attorneys identify which companies’ asbestos-containing products you were exposed to. Exposure may have occurred on the job, during home renovations, or through asbestos fibers brought home on a family member’s work clothes. Call The Halpern Law Firm at 800-505-6000 or request a free case review.
Sources:
